WithdrawnNot Applicable

Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction

Stopped: No participants enrolled

United States0Started 2023-03

Plain-language summary

The purpose of this research is to determine the pure or additional effects of penile shockwave therapy with low intensity linear shock wave machine for penile curvature (and/or erectile dysfunction) vs patients' undergoing other treatments (including Xiaflex therapy, patients that have undergone older generations of SWT, or medical treatment).

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Peyronie's Disease (PD) at any stage * The presence of penile plaque or pain at erection or curvature * PD therapy with or without simultaneous intralesional Xiaflex injection. Exclusion Criteria: * Prior penile surgery or LiSWT. * Erective Dysfunction (ED) not responding to phosphodiesterase-type five inhibitors or intracavernosal injections. * Unwillingness or inability to provide informed consent. * Having active or life-threatening coagulopathies ore using anti-coagulation /anti-platelet medications

What they're measuring

Change in penile curvature

Timeframe: Baseline, 10 weeks

Trial details

NCT IDNCT05646602

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

View on ClinicalTrials.gov More Peyronie Disease trials